August 2025
1. AITHAL GP
   From Long to Snappy and Short Regimens for Paracetamol Overdose: Reinventing the N-Acetyl Cysteine Wheel.
   J Hepatol. 2025 Aug 11:S0168-8278(25)02403-1. doi: 10.1016/j.jhep.2025.
   

   >> Share

   
   June 2025
2. INDIA-ALDANA S, Midya V, Betanzos-Robledo L, Yao M, et al
   Impact of metabolism-disrupting chemicals and folic acid supplementation on liver injury and steatosis in mother-child pairs.
   J Hepatol. 2025;82:956-966.
   

   >> Share

   
   May 2025
3. ISBISTER G, Chiew A, Buckley N, Harris K, et al
   A non-inferiority randomised controlled trial of a Shorter Acetylcysteine Regimen for Paracetamol Overdose - the SARPO trial.
   J Hepatol. 2025 May 23:S0168-8278(25)02206-8. doi: 10.1016/j.jhep.2025.
   

   >> Share

   
   October 2024
4. SEGOVIA-ZAFRA A, Villanueva-Paz M, Serras AS, Matilla-Cabello G, et al
   Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
   J Hepatol. 2024;81:630-640.
   

   >> Share

   
   September 2024
5. MYOTERI D, Grypari IM, Schina M, Lohse A, et al
   An overweight female with a history of allergies and drug-induced liver injury.
   J Hepatol. 2024;81:e93-e95.
   

   >> Share

   
   March 2024
6. BJORNSSON ES, Lucena MI, Andrade RJ
   Reply to the Letter to the Editor: Distinction of Autoimmune Hepatitis from Drug Induced Autoimmune Like Hepatitis: The Answer Lies at the Interface.
   J Hepatol. 2024 Mar 28:S0168-8278(24)00221-6. doi: 10.1016/j.jhep.2024.
   

   >> Share

   
   February 2024
7. ALKASHASH A, Zhang X, Vuppalanchi R, Lammert C, et al
   Distinction of Autoimmune Hepatitis from Drug Induced Autoimmune Like Hepatitis: The Answer Lies at the Interface.
   J Hepatol. 2024 Feb 1:S0168-8278(24)00100-4. doi: 10.1016/j.jhep.2024.
   

   >> Share

   
   September 2023
8. UZUN S, Zinner CP, Beenen AC, Alborelli I, et al
   Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics.
   J Hepatol. 2023;79:666-676.
   

   >> Share

   
   August 2023
9. ROMA K, Mohammed S, Sieck B, Naik K, et al
   Kratom-induced acute liver injury: A case study and the importance of herbal supplement regulation.
   J Hepatol. 2023;79:581-584.
   

   >> Share

   
   May 2023
10. ANDRADE RJ, Aithal GP, de Boer YS, Liberal R, et al
    Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report.
    J Hepatol. 2023 May 8:S0168-8278(23)00320-3. doi: 10.1016/j.jhep.2023.
    

    >> Share

    
    
11. ZHANG CJ, Meyer SR, O'Meara MJ, Huang S, et al
    A human liver organoid screening platform for DILI risk prediction.
    J Hepatol. 2023;78:998-1006.
    

    >> Share

    
    
12. DALY AK, Bjornsson ES, Lucena MI, Andrade RJ, et al
    Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but different HLA risk alleles in an independent cohort.
    J Hepatol. 2023;78:e165-e166.
    

    >> Share

    
    March 2023
13. JAGADISAN B, Dhawan A
    Multidisciplinary approach and reactive immunosuppression for gene therapy related hepatotoxicity.
    J Hepatol. 2023 Mar 28:S0168-8278(23)00197-6. doi: 10.1016/j.jhep.2023.
    

    >> Share

    
    
14. NOGUEIRAS R, Aspichueta P
    Expanding the roles of the renin-angiotensin system: Drug-induced liver injury.
    J Hepatol. 2023;78:457-459.
    

    >> Share

    
    November 2022
15. CHEN S, Lu Z, Jia H, Yang B, et al
    Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice.
    J Hepatol. 2022 Nov 9. pii: S0168-8278(22)03285.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share